Core Insights - The article discusses a long-term investment strategy focused on buying stocks with options to enhance returns and mitigate risks through the sale of out-of-the-money covered calls that can be rolled forward [1]. Group 1 - The individual mentioned has extensive experience in academia and finance, including roles as a CFO, government auditor, and public accountant, and has authored numerous publications [2]. - The individual has a history of teaching at multiple universities and has been involved in significant fraud cases, with research utilized by the SEC [2]. - The individual has faced serious health challenges but has achieved a three-year period of clean test results, leading to a relocation to the Philippines for travel and new experiences [2]. Group 2 - The analyst has disclosed a beneficial long position in NEOG shares, indicating personal investment in the company through various financial instruments [3]. - The article emphasizes that the opinions expressed are personal and not influenced by compensation from any company mentioned [3].

NEW YORK , Sept. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG). ...

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neogen Corporation investors who were adversely affected by alleged securities fraud between January 5, 2023 and June 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/neoge ...

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the important September 16, 2025 lead plaintiff deadline. SO WHAT: If you purchased Neogen common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [3]. Group 1 - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [3]. - Allegations include that the company downplayed inefficiencies arising from the integration and assured investors of their commitment to resolving these issues quickly [3]. - Shareholders are encouraged to register for the class action by September 16, 2025, to potentially become lead plaintiffs [4]. Group 2 - The Gross Law Firm is representing the shareholders and is recognized for protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025 (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline.So what: If you purchased Neogen common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Ne ...

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with the Food Safety Division of 3M Company [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1]. - Defendants allegedly issued false statements about the progress of the integration, leading investors to have an inflated perception of its success [2]. - When inefficiencies from the integration were revealed, the defendants downplayed these issues and assured investors of their commitment to resolving them [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]. - The firm has over 70 employees dedicated to serving clients in complex securities litigation [4].

Group 1 - The Rosen Law Firm is reminding purchasers of Neogen Corporation common stock from January 5, 2023, to June 3, 2025, about the September 16, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Neogen common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2] - A class action lawsuit has already been filed, and interested parties must move the Court by September 16, 2025, to serve as lead plaintiff [2] Group 2 - The lawsuit alleges that Neogen's defendants made false and misleading statements regarding the integration process, leading investors to believe it was progressing smoothly [4] - At the start of the Class Period, defendants claimed the integration was "off to a great start" and highlighted solid core growth and profitability, which later proved to be misleading [4] - The lawsuit claims that when the true details about the integration issues became known, investors suffered damages [4] Group 3 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [3]

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged misleading statements and failure to disclose material facts regarding the integration of 3M's Food Safety Division, leading to significant financial losses for investors [1][4][7]. Group 1: Company Overview - Neogen Corporation develops, manufactures, and markets products focused on food and animal safety, and completed a strategic merger with 3M's Food Safety Division in September 2022 [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Neogen misrepresented the progress of the integration, which was actually facing operational and financial difficulties [5]. - Neogen reported a GAAP net loss of $461 million due to a non-cash goodwill impairment related to the 3M acquisition, along with downward revisions to revenue and EBITDA guidance for 2025 [5]. - Following the announcement of a Q3 net loss of $11 million and a 3.4% revenue decline to $221 million, Neogen's stock fell approximately 28% [5][6]. - The company also disclosed an expected drop in EBITDA margin to the "high-teens" from 22%, attributed to elevated inventory write-offs, resulting in a further decline of over 17% in share price [6].

Core Points - Rosen Law Firm is reminding purchasers of Neogen Corporation common stock from January 5, 2023, to June 3, 2025, about the September 16, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Neogen stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Company Details - The lawsuit alleges that Neogen's management made false and misleading statements regarding the integration process, claiming it was progressing smoothly while it was not [4] - Initially, Neogen's management stated that the integration was "off to a great start" and highlighted solid core growth and profitability, which later proved to be misleading [4] - The lawsuit claims that when the true state of the integration was revealed, investors suffered damages due to the misleading information provided by the company [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience [3] - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been ranked highly for its performance in securities class action settlements [3]